Prior knowledge of HPV status improves detection of CIN2+ by cytology screening

被引:46
作者
Benoy, Ina H. [1 ]
Vanden Broeck, Davy [3 ]
Ruymbeke, Maya J. [4 ]
Sahebali, Shaira
Arbyn, Marc [5 ]
Bogers, Johannes J. [1 ,2 ]
Temmerman, Marleen [3 ]
Depuydt, Christophe E. [1 ]
机构
[1] Dept Mol Pathol RIATOL Son Healthcare, Antwerp, Belgium
[2] Univ Antwerp, Dept Appl Mol Biol Res AMBIOR, B-2020 Antwerp, Belgium
[3] Univ Ghent, ICRH, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Dept Obstet & Gynaecol, B-9000 Ghent, Belgium
[5] Sci Inst Publ Hlth, Belgian Canc Ctr, Canc Epidemiol Unit, Brussels, Belgium
关键词
cervical cancer; cervical cytology; human papillomavirus; human papillomavirus genotypes; real-time polymerase chain reaction; CERVICAL-CANCER; SYSTEM;
D O I
10.1016/j.ajog.2011.06.101
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The objective of the study was to investigate whether knowledge of human papillomavirus (HPV) deoxyribonucleic acid test results increases sensitivity of guided cytology screening for the detection of cervical intraepithelial neoplasia (CIN)-2 or higher-grade cervical lesions. STUDY DESIGN: This was a prospective colposcopy-controlled study of 2905 BD SurePath samples to identify cases with CIN2+ within a 24 month follow-up period. Sensitivity and specificity to detect CIN2+ was evaluated, comparing guided cytology screening with and without prior knowledge of HPV status. RESULTS: Prior knowledge of HPV status resulted in significantly higher detection rate of CIN2+ compared with screening blinded to HPV status (P = .005) with limited loss of specificity (P = .026). Gain in sensitivity is higher in older women (43.8%, P = .008) vs in younger women (10.2%, P = .317), whereas loss of specificity is more pronounced in younger women (P < .001) vs older women (P = .729). CONCLUSION: Guided cytological screening performed with prior knowledge of HPV status results in an improved detection of CIN2 or higher-grade lesions.
引用
收藏
页码:569.e1 / 569.e7
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 2007, An introduction to categorical data analysis
[2]   Trials comparing cytology with human papillomavirus screening [J].
Arbyn, M. ;
Ronco, G. ;
Meijer, C. J. L. M. ;
Naucler, P. .
LANCET ONCOLOGY, 2009, 10 (10) :935-936
[3]   Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium [J].
Arbyn, Marc ;
Benoy, Ina ;
Simoens, Cindy ;
Bogers, Johannes ;
Beutels, Philippe ;
Depuydt, Christophe .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (01) :321-330
[4]   Liquid compared with conventional cervical cytology - A systematic review and meta-analysis [J].
Arbyn, Marc ;
Bergeron, Christine ;
Klinkhamer, Paul ;
Martin-Hirsch, Pierre ;
Siebers, Albertus G. ;
Bulten, Johan .
OBSTETRICS AND GYNECOLOGY, 2008, 111 (01) :167-177
[5]   Clinical applications of HPV testing: A summary of meta-analyses [J].
Arbyn, Marc ;
Sasieni, Peter ;
Meijer, Chris J. L. M. ;
Clavel, Christine ;
Koliopoulos, George ;
Dillner, Joakim .
VACCINE, 2006, 24 :78-89
[6]  
BREITENECKER G, 2009, PATHOLOGE, V2, P128
[7]   Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries [J].
Cuzick, Jack ;
Arbyn, Marc ;
Sankaranarayanan, Rengaswamy ;
Tsu, Vivien ;
Ronco, Guglielmo ;
Mayrand, Marie-Helene ;
Dillner, Joakim ;
Meijer, Chris J. L. M. .
VACCINE, 2008, 26 :K29-K41
[8]   Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types [J].
Depuydt, C. E. ;
Boulet, G. A. V. ;
Horvath, C. A. J. ;
Benoy, I. H. ;
Vereecken, A. J. ;
Bogers, J. J. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (04) :881-891
[9]   Improved endocervical sampling and HPV viral load detection by Cervex-Brush® Combi [J].
Depuydt, C. E. ;
Benoy, I. H. ;
Bailleul, E. J. ;
Vandepitte, J. ;
Vereecken, A. J. ;
Bogers, J. J. .
CYTOPATHOLOGY, 2006, 17 (06) :374-381
[10]  
Field A., 2009, Discovering statistics with SPSS, V3rd